etripamil

FDA Drug Profile — Cardamyst

etripamil is listed in the FDA National Drug Code directory with 2 NDC codes, marketed under brand name including Cardamyst. Available dosage form: spray.

Drug details

Generic Name
etripamil
Brand Names
Cardamyst
Application Number
NDA218571
Sponsor
Milestone Pharmaceuticals USA, Inc.
NDC Codes
2
Dosage Forms
SPRAY
Routes
NASAL
Active Ingredients
ETRIPAMIL

Indications and Usage

1 INDICATIONS AND USAGE CARDAMYST is indicated for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. CARDAMYST is a calcium channel blocker indicated for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults ( 1 ).

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.